Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
Andreas Schneeweiß, Volker J. Möbus, Hans Tesch, Claus Alexander Hanusch, Carsten Denkert, Kristina Lübbe and 17 more
- Rank
- 33 of 981
- Percentile
- top 3.4%
- Where
- European Journal of Cancer, 2018
- Citations
- 105
From the 2018 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.